Skip to main content
Clinical Trials/NCT03294980
NCT03294980RecruitingNot Applicable

Chronic Lymphoid Leukaemia Observatory in Finistere Area, France

University Hospital, Brest1 site in 1 country3,000 target enrollmentStarted: November 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
3,000
Locations
1
Primary Endpoint
Prevalence

Study Overview

Brief Summary

Brief Summary: The purpose of the OFICE registry is to characterize and describe the CLL patients' population from the Finistere area and evaluates the association between different patient characteristics, prognosis and treatment patterns.

Detailed Description: OFICE is a single center, prospective, observational registry of CLL patients designed to provide a general description of the CLL patients' population from the Finistere area, France. The registry will also provide information on the association of cytogenetic and immunophenotypic characteristics with disease progression, as well as treatment patterns and healthcare resource utilization. These data will be accessible and beneficial for researchers and physicians and will help guide clinical practice and future clinical or fundamental studies.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age of at least 18 years
  • Clinical diagnosis of CLL/SLL that meets published diagnostic criteria (Hallek 2008)
  • Willing and able to provide informed consent
  • Willing and able to provide blood sample at time of enrollment

Exclusion Criteria

  • Diagnosis of other B-cell malignancies

Outcomes

Primary Outcomes

Prevalence

Time Frame: Year 0 (Y)

Clinical data

Secondary Outcomes

  • Incidence(Year 0)
  • Description of baseline clinical-biological(Year 0, Year 1, Year 2, Year 3)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials